Project Description

Sublimity Therapeutics formerly Sigmoid PharmaSigmoid’s goal is to identify and create meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases and disorders. The company has recently been renamed as Sublimity Therapeutics.

Sublimity Therapeutics (formerly Sigmoid Pharma) Website>>
Irish Times Article relating to Sublimity Therapeutics, May 2018>>

If you are interested in becoming an Investor or seeking investment, then please contact us.